PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Immunology and Immunotherapy Division, Center of Molecular Immunology (CIM), P.O. Box 16040, 216 St., Havana, Cuba.\', \'National Laboratory of Civil Defense (NLCD), Jamaica Highway and National Highway, San José of Lajas, Mayabeque, Cuba.\', \'Quality Control Department, Center of Molecular Immunology (CIM), P.O. Box 16040, 216 St., Havana, Cuba.\', \'Finlay Vaccine Institute (IFV), 200 and 21 Street, Havana 11600, Cuba.\', \'Institute of Hematology and Immunology (IHI), Havana, Cuba.\', \'Immunology and Immunotherapy Division, Center of Molecular Immunology (CIM), P.O. Box 16040, 216 St., Havana, Cuba. Electronic address: tays@cim.sld.cu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(22)00190-610.1016/j.vaccine.2022.02.044
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 35193792
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35193792>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35193792>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all